Eugene Frederick Leffler - 10 Jan 2023 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Role
Chief Financial Officer
Signature
/s/ Daniel Hakansson, Attorney-in-fact for Eugene Frederick Leffler III
Issuer symbol
BFRI
Transactions as of
10 Jan 2023
Net transactions value
$0
Form type
4
Filing time
12 Jan 2023, 18:06:09 UTC
Previous filing
04 Nov 2022
Next filing
16 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BFRI Employee stock option (right to buy) Award $0 +100,000 $0.000000 100,000 10 Jan 2023 Common Stock 100,000 $0.9651 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in three equal annual installments beginning on the first anniversary of the grant date (01/10/2024).